China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
Want to see HK:2877 full AI Analyst Report?
Total Valuation
China Shineway Pharmaceutical Group Limited has a market cap or net worth of HK$7.33B. The enterprise value is -HK$368.05M.
Market CapHK$7.33B
Enterprise Value-HK$368.05M
Share Statistics
China Shineway Pharmaceutical Group Limited has 827,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding827,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Shineway Pharmaceutical Group Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 5.78%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)5.78%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee948.53K
Profits Per Employee394.18K
Employee Count3,220
Asset Turnover0.28
Inventory Turnover1.22
Valuation Ratios
The current PE Ratio of China Shineway Pharmaceutical Group Limited is 6.3. China Shineway Pharmaceutical Group Limited’s PEG ratio is 0.64.
PE Ratio6.3
PS Ratio1.91
PB Ratio0.72
Price to Fair Value0.72
Price to FCF5.99
Price to Operating Cash Flow5.08
PEG Ratio0.64
Income Statement
In the last 12 months, China Shineway Pharmaceutical Group Limited had revenue of 3.05B and earned 925.36M in profits. Earnings per share was 1.22.
Revenue3.05B
Gross Profit2.21B
Operating Income664.41M
Pretax Income1.24B
Net Income925.36M
EBITDA733.46M
Earnings Per Share (EPS)1.22
Cash Flow
In the last 12 months, operating cash flow was 1.26B and capital expenditures -198.14M, giving a free cash flow of 1.06B billion.
Operating Cash Flow1.26B
Free Cash Flow1.06B
Free Cash Flow per Share1.28
Dividends & Yields
China Shineway Pharmaceutical Group Limited pays an annual dividend of HK$0.12, resulting in a dividend yield of 5.8%
Dividend Per ShareHK$0.12
Dividend Yield5.8%
Payout Ratio41.98%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change35.61%
50-Day Moving Average9.41
200-Day Moving Average8.75
Relative Strength Index (RSI)60.84
Average Volume (3m)1.29M
Important Dates
China Shineway Pharmaceutical Group Limited upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
China Shineway Pharmaceutical Group Limited as a current ratio of 3.71, with Debt / Equity ratio of 4.15%
Current Ratio3.71
Quick Ratio3.43
Debt to Market Cap0.06
Net Debt to EBITDA-9.35
Interest Coverage Ratio119.98
Taxes
In the past 12 months, China Shineway Pharmaceutical Group Limited has paid 311.05M in taxes.
Income Tax311.05M
Effective Tax Rate0.25
Enterprise Valuation
China Shineway Pharmaceutical Group Limited EV to EBITDA ratio is -1.39, with an EV/FCF ratio of -1.05.
EV to Sales-0.33
EV to EBITDA-1.39
EV to Free Cash Flow-1.05
EV to Operating Cash Flow-0.87
Balance Sheet
China Shineway Pharmaceutical Group Limited has HK$7.57B in cash and marketable securities with HK$335.05M in debt, giving a net cash position of HK$7.23B billion.
Cash & Marketable SecuritiesHK$7.57B
Total DebtHK$335.05M
Net CashHK$7.23B
Net Cash Per ShareHK$8.75
Tangible Book Value Per ShareHK$10.44
Margins
Gross margin is 72.28%, with operating margin of 21.75%, and net profit margin of 30.30%.
Gross Margin72.28%
Operating Margin21.75%
Pretax Margin40.48%
Net Profit Margin30.30%
EBITDA Margin24.01%
EBIT Margin21.75%
Analyst Forecast
The average price target for China Shineway Pharmaceutical Group Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-17.03%
EPS Growth Forecast12.82%